Clinicopathological characteristics and treatment outcome in obese patients with diffuse large B-cell lymphoma

BACKGROUND: Aberrant MYC and BCL2 expression, cell of origin (COO), and National Comprehensive Cancer Network international prognostic index (NCCN-IPI) are commonly used for risk assessment and treatment decision in patients with diffuse large B-cell lymphoma (DLBCL). Although obesity has been shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-Ying, You, Jie-Yu, Huang, Cih-En, Hsu, Chia-Chen, Chen, Yi-Yang, Tsou, Hsing-Yi, Chen, Ying-Ju, Li, Chian-Pei, Lai, Yi-Hua, Lu, Chang-Hsien, Chen, Ping-Tsung, Chen, Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797893/
https://www.ncbi.nlm.nih.gov/pubmed/35117223
http://dx.doi.org/10.21037/tcr-20-1362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797893/
https://www.ncbi.nlm.nih.gov/pubmed/35117223
http://dx.doi.org/10.21037/tcr-20-1362

Ejemplares similares